Have a feature idea you'd love to see implemented?
Let us know!
PLUR Pluri Inc
Price (delayed)
$4.75
Market cap
$25.98M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.99
Enterprise value
$48.56M
Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented
Highlights
Pluri's EPS has increased by 36% YoY and by 3.4% QoQ
The net income is up by 26% year-on-year and by 3.4% since the previous quarter
The equity has soared by 127% from the previous quarter but it has plunged by 99% YoY
The quick ratio has grown by 17% from the previous quarter but it has contracted by 6% YoY
Key stats
What are the main financial stats of PLUR
Market
Valuations
Earnings
Shares outstanding
5.47M
Market cap
$25.98M
Enterprise value
$48.56M
Price to earnings (P/E)
N/A
Price to book (P/B)
266.63
Price to sales (P/S)
76.35
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
148.95
Revenue
$326,000
EBIT
-$21.7M
EBITDA
-$21.45M
Free cash flow
-$18.34M
Per share
Balance sheet
Liquidity
EPS
-$3.99
Free cash flow per share
-$3.5
Book value per share
$0.02
Revenue per share
$0.06
TBVPS
$7.54
Total assets
$39.53M
Total liabilities
$34.11M
Debt
$29.61M
Equity
$96,000
Working capital
$26.65M
Debt to equity
308.46
Current ratio
6.98
Quick ratio
6.79
Net debt/EBITDA
-1.05
Margins
Efficiency
Dividend
EBITDA margin
-6,579.4%
Gross margin
98.8%
Net margin
-6,407.4%
Operating margin
-6,796.9%
Return on assets
-51.6%
Return on equity
-640.7%
Return on invested capital
-36.5%
Return on capital employed
-61.9%
Return on sales
-6,657.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PLUR stock price
How has the Pluri stock price performed over time
Intraday
0%
1 week
-4.27%
1 month
-11.21%
1 year
22.42%
YTD
2.37%
QTD
-21.48%
Financial performance
How have Pluri's revenue and profit performed over time
Revenue
$326,000
Gross profit
$322,000
Operating income
-$22.16M
Net income
-$20.89M
Gross margin
98.8%
Net margin
-6,407.4%
PLUR's net margin is up by 35% year-on-year
Pluri's operating margin has increased by 28% YoY but it has decreased by 2.2% QoQ
The net income is up by 26% year-on-year and by 3.4% since the previous quarter
The operating income has increased by 19% YoY and by 2.2% from the previous quarter
Growth
What is Pluri's growth rate over time
Valuation
What is Pluri stock price valuation
P/E
N/A
P/B
266.63
P/S
76.35
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
148.95
Pluri's EPS has increased by 36% YoY and by 3.4% QoQ
The equity has soared by 127% from the previous quarter but it has plunged by 99% YoY
PLUR's P/S is 14% below its last 4 quarters average of 89.2
Pluri's revenue has increased by 14% YoY but it has decreased by 4.4% from the previous quarter
Efficiency
How efficient is Pluri business performance
Pluri's return on equity has shrunk by 95% QoQ
Pluri's return on sales has increased by 28% YoY but it has decreased by 14% QoQ
PLUR's return on invested capital is down by 14% since the previous quarter
Pluri's return on assets has decreased by 3.4% QoQ and by 3.2% YoY
Dividends
What is PLUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PLUR.
Financial health
How did Pluri financials performed over time
The company's total assets is 16% higher than its total liabilities
The company's total assets fell by 22% YoY but it rose by 9% QoQ
The quick ratio has grown by 17% from the previous quarter but it has contracted by 6% YoY
The equity has soared by 127% from the previous quarter but it has plunged by 99% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.